Virtual Reality Analgesia During Pediatric Physical Therapy
Status: | Completed |
---|---|
Healthy: | No |
Age Range: | 5 - 20 |
Updated: | 3/15/2019 |
Start Date: | May 2009 |
End Date: | April 2017 |
We would like to determine whether Virtual Reality (VR) analgesia continues to be effective
for reducing pain when administered for a clinically relevant treatment duration over
multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).
for reducing pain when administered for a clinically relevant treatment duration over
multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).
This study is done in a hospital for inpatients pediatrics. By randomization some subjects
will immersive Virtual Reality (VR) during a painful procedure on daily basis up to 10 days
to see whether this will reduce the pain and anxiety.
will immersive Virtual Reality (VR) during a painful procedure on daily basis up to 10 days
to see whether this will reduce the pain and anxiety.
Inclusion Criteria:
- Age greater than or equal to 8 years up to 20 yrs old
- Compliant and able to complete subject evaluation
- A minimum of 3 days of physical therapy, one physical therapy session per day
- No history of psychiatric (DSM-IV-R Axis I) or developmental disorder that would
interfere with decisional capacity
- Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder that
would interfere with decisional capacity
- Able to communicate verbally
- Able to take oral medications
- English-speaking
Exclusion Criteria:
- - Age less than 8 years, or greater than 20 years.
- Not capable of indicating pain intensity
- Not capable of filling out study measures
- Hospitalization of fewer than 3 days
- Evidence of traumatic brain injury
- History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and
MD admission notes, if interfering with decisional capacity
- Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated
memory problems that would interfere with decisional capacity
- Unable to communicate verbally
- Unable to take oral medications
- History of sig. cardiac, endocrine, neurologic, metabolic, respiratory,
gastrointestinal or genitourinary impairment that would interfere with treatment or
decisional capacity
- Receiving prophylaxis for alcohol or drug withdrawal
- Developmental disability that would interfere with decisional capacity
- Face/head/neck injuries preventing helmet use
- Non-English-speaking
- Extreme susceptibility to motion sickness
- Seizure history
We found this trial at
1
site
325 9th Ave
Seattle, Washington 98104
Seattle, Washington 98104
(206) 744-3300
Principal Investigator: David R Patterson, Ph.D.
Phone: 206-744-3418
Harborview Medical Center Harborview Medical Center is the only designated Level 1 adult and pediatric...
Click here to add this to my saved trials